CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
1.17
10.38%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023374 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023374%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001151 %
Charges from full value of position ($0.22)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001151%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.06
Open 1.05
1-Year Change -43.55%
Day's Range 1.05 - 1.18
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 20, 2024 1.17 0.12 11.43% 1.05 1.18 1.04
Dec 19, 2024 1.06 0.04 3.92% 1.02 1.08 0.97
Dec 18, 2024 1.00 -0.08 -7.41% 1.08 1.09 0.98
Dec 17, 2024 1.06 -0.07 -6.19% 1.13 1.14 1.02
Dec 16, 2024 1.13 -0.03 -2.59% 1.16 1.18 1.10
Dec 13, 2024 1.12 -0.14 -11.11% 1.26 1.26 1.09
Dec 12, 2024 1.17 -0.09 -7.14% 1.26 1.26 1.17
Dec 11, 2024 1.24 -0.01 -0.80% 1.25 1.26 1.22
Dec 10, 2024 1.25 -0.01 -0.79% 1.26 1.29 1.17
Dec 9, 2024 1.24 -0.04 -3.13% 1.28 1.35 1.23
Dec 6, 2024 1.27 -0.01 -0.78% 1.28 1.28 1.22
Dec 5, 2024 1.26 -0.05 -3.82% 1.31 1.31 1.23
Dec 4, 2024 1.33 -0.02 -1.48% 1.35 1.37 1.29
Dec 3, 2024 1.34 -0.05 -3.60% 1.39 1.39 1.32
Dec 2, 2024 1.40 -0.07 -4.76% 1.47 1.48 1.37
Nov 29, 2024 1.50 0.07 4.90% 1.43 1.52 1.43
Nov 27, 2024 1.40 -0.02 -1.41% 1.42 1.51 1.40
Nov 26, 2024 1.42 0.03 2.16% 1.39 1.45 1.32
Nov 25, 2024 1.38 -0.01 -0.72% 1.39 1.54 1.38
Nov 22, 2024 1.33 0.05 3.91% 1.28 1.46 1.26

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Generation Bio Co. Company profile

About Generation Bio Co

Generation Bio Co. is genetic medicines to provide treatments of rare and prevalent diseases. The Company through its non-viral genetic medicine platform, is engaged in developing genetic medicines to provide genetic payloads, which include large and multiple genes to a range of cell types across a range of diseases. It is comprised of three component technologies: ceDNA, ctLNP and ceDNA manufacturing process. ceDNA is an engineered, double-stranded, linear, covalently closed-ended deoxyribonucleic acid (DNA) construct, which includes the gene of interest and associated regulatory sequences. It has produced ceDNA constructs of approximately eight kilobases. Its ctLNP delivery system builds upon clinically validated lipid nanoparticles and is designed to allow for repeat dosing of a genetic payload without stimulating an immune response, such as antibody production. Its ceDNA manufacturing process uses its own cell-free rapid enzymatic synthesis (RES) to produce ceDNA.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Generation Bio Co revenues was not reported. Net loss increased 48% to $119.2M. Higher net loss reflects alancing val increase of 39% to $51M (expense), Labor & Related Expenses in R&D increase of 43% to $24.9M (expense), Stock-based Compensation in R&D increase from $4.3M to $9.3M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.74 to -$2.12.

Industry: Bio Therapeutic Drugs

301 Binney Street
CAMBRIDGE
MASSACHUSETTS 02142
US

People also watch

ETH/USD

3,307.13 Price
-0.400% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

US100

21,269.40 Price
+0.710% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

95,383.25 Price
-1.600% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

XRP/USD

2.22 Price
-0.600% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01109

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading